The Alzheimer’s Drug Discovery Foundation (ADDF) has awarded Italian biotechnology company Axxam SpA a $340,485 grant…
Ana de Barros, PhD
Ana holds a PhD in immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. Ana was awarded two FCT fellowships and has won the Portuguese Immunology Society Best Paper and Best Poster award in 2009 and 2010, as well as the CESPU International Research Award in 2010. After leaving the lab to pursue a career in science communication, she served as the director of science communication at iMM Lisbon.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana de Barros, PhD
The head of the Division of Memory Disorders of the University of Alabama at Birmingham…
Eli Lilly and Company and AstraZeneca, who previously partnered to study an investigational treatment for Alzheimer’s…
A recent study published in the journal eLife suggests that it might be possible to restore…
The U.S. Food and Drug Administration (FDA) has granted Arjuna Natural Extracts Ltd. a U.S. patent for…
A Stanford University School of Medicine study recently published in the Journal of Clinical Investigation, entitled…
A study entitled “Enhancing dentate gyrus function with dietary flavanols improves cognition in older adults,” published this month…
A drug that is usually used for treatment of psoriasis has been found to stimulate the activity of the…
A new study published this week in the Journal of Neuroscience suggests a potential therapy for a type…
According to the Institute for Scientific Information on Coffee (ISIC), a nonprofit organization that specializes in biomedical research and…